Swiss - Delayed Quote
CHF
Galderma Group AG (GALD.SW)
192.85
+3.15
(+1.66%)
At close: October 30 at 5:30:30 PM GMT+1
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
|
CEO & Director | 6.03M | -- | 1958 |
|
Mr. Luigi Felice La Corte
|
Chief Financial Officer | -- | -- | 1969 |
|
Mr. Adrian Murphy
|
Head of Global Operations | -- | -- | 1970 |
|
Mr. Emil Ivanov
|
Head of Strategy, Investor Relations & ESG | -- | -- | -- |
|
Ms. Desislava Lazarova M.D.
|
Global Head of Customer Education & Training | -- | -- | -- |
Galderma Group AG
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 7,676
Description
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Corporate Governance
Galderma Group AG’s ISS Governance QualityScore as of October 1, 2026 is 5. The pillar scores are Audit: 8; Board: 3; Shareholder Rights: 1; Compensation: 9.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
April 24, 2026 at 12:00 AM UTC
Ex-Dividend Date
April 29, 2025 at 12:00 AM UTC
Dividend Date
